logo-loader
viewRapid Nutrition PLC

Full interview: Rapid Nutrition set to launch new oral anti viral therapy to combat common cold

Rapid Nutrition (OTCQB; RPNRF) CEO Simon St. Ledger joined Steve Darling from Proactive Vancouver with news the company is preparing to launch a new oral anti-viral treatment called Azurene that is designed to combat the common cold in humans. 

St Ledger telling Proactive this anti-viral formula relates to the use of a combination of herbal extracts may assist in providing a broad spectrum of protection, treatment and relief for a broad range of viral infections, including the common cold.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Britvic PLC sees acceleration in at-home channel sales lead by Pepsi-MAX in...

Britvic PLC (OTCQX:BTVCF) (LON:BVIC) Director of Investor Relations Stephen Nightingale tells Proactive the manufacturer of soft drinks saw an increase at-home channel sales with its slew of trusted soft drinks, despite a months-wide lockdown in the UK. Nightingale says its carbonates...

12 hours, 13 minutes ago

2 min read